Call for pharmacist access to the MBS for Chronic Disease Management

0
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Treating hypertension – a new approach

0
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Harnessing different abilities

0
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...

Aged care in focus

0
The Royal Commission into Aged Care Quality and Safety has heard clear calls for pharmacists, as a priority, to spend more time on the...

PSA’s projects make a bigger impact than ever before

0
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Resistance movement: Pharmacy’s fight against antimicrobial resistance

0
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...